Production (Stage)
SANUWAVE Health, Inc.
SNWV
$28.55
-$0.32-1.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 47.64% | 88.98% | 53.20% | 53.27% | 27.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.64% | 88.98% | 53.20% | 53.27% | 27.16% |
| Cost of Revenue | 5.84% | 62.39% | 59.90% | 25.52% | 81.43% |
| Gross Profit | 66.31% | 99.58% | 50.88% | 67.21% | 12.18% |
| SG&A Expenses | 48.50% | 27.61% | 29.65% | 17.65% | -37.12% |
| Depreciation & Amortization | 16.93% | 10.16% | -3.74% | -3.70% | -1.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.05% | 35.07% | 38.09% | 18.82% | -14.48% |
| Operating Income | 142.73% | 467.80% | 113.96% | 46.92% | 171.02% |
| Income Before Tax | -169.75% | 12.84% | 190.35% | 65.38% | 420.26% |
| Income Tax Expenses | 575.00% | -- | -- | -- | 100.00% |
| Earnings from Continuing Operations | -169.91% | 12.84% | 190.35% | 65.38% | 420.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -169.91% | 12.84% | 190.35% | 65.38% | 420.08% |
| EBIT | 142.73% | 467.80% | 113.96% | 46.92% | 171.02% |
| EBITDA | 127.74% | 930.45% | 89.89% | 51.60% | 207.97% |
| EPS Basic | -124.92% | 34.84% | 144.49% | 82.87% | 262.37% |
| Normalized Basic EPS | -127.05% | 34.84% | 108.48% | 83.27% | 265.99% |
| EPS Diluted | -124.92% | 34.84% | 137.91% | 82.87% | 244.68% |
| Normalized Diluted EPS | -127.05% | 34.84% | 107.23% | 83.27% | 265.99% |
| Average Basic Shares Outstanding | 180.57% | 33.77% | 103.08% | 102.13% | 97.13% |
| Average Diluted Shares Outstanding | 180.57% | 33.77% | 138.30% | 102.13% | 97.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |